Clinical Trial Update: Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On Therapy Trial [Phase 4]

View source ↗

Summary

Open-label Phase 4 trial of pregabalin as add-on therapy for partial seizures was terminated; results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial Seizures

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Partial Seizures | Phase 4 | Status: TERMINATED | Results posted: 2010-09-09